These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 1435931

  • 1. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome.
    Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K.
    N Engl J Med; 1992 Dec 17; 327(25):1774-8. PubMed ID: 1435931
    [Abstract] [Full Text] [Related]

  • 2. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
    Zipser RD, Radvan GH, Kronborg IJ, Duke R, Little TE.
    Gastroenterology; 1983 Apr 17; 84(4):697-703. PubMed ID: 6572162
    [Abstract] [Full Text] [Related]

  • 3. [Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome].
    Møller S, Henriksen JH.
    Ugeskr Laeger; 1993 Mar 08; 155(10):728-9. PubMed ID: 8456518
    [No Abstract] [Full Text] [Related]

  • 4. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
    Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC.
    N Engl J Med; 1991 Oct 03; 325(14):997-1001. PubMed ID: 1886637
    [Abstract] [Full Text] [Related]

  • 5. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T, Pacher R, Wimmer A, Bojic A, Hülsmann M, Frey B, Mayer G, Yilmaz N, Skvarilova L, Spinar J, Vitovec J, Toman J, Woloszcuk W, Stanek B.
    Wien Klin Wochenschr; 1998 Feb 13; 110(3):89-95. PubMed ID: 9553203
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma endothelin and the hepatorenal syndrome.
    Agarwal R.
    N Engl J Med; 1993 Jul 01; 329(1):63. PubMed ID: 8505956
    [No Abstract] [Full Text] [Related]

  • 8. Elevated plasma levels of endothelin in patients with sepsis syndrome.
    Weitzberg E, Lundberg JM, Rudehill A.
    Circ Shock; 1991 Apr 01; 33(4):222-7. PubMed ID: 2065442
    [Abstract] [Full Text] [Related]

  • 9. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K, Kubo M, Masuda K, Tokumoto M, Hirakawa M, Ikeda H, Matsui R, Matsuo D, Fukuda K, Kanai H, Hirakata H, Iida M.
    Clin Exp Nephrol; 2003 Dec 01; 7(4):279-83. PubMed ID: 14712357
    [Abstract] [Full Text] [Related]

  • 10. Frequency of hepatorenal syndrome among cirrhotics.
    Kumar R, Ahmed R, Rathi SK, Sethar GH.
    J Coll Physicians Surg Pak; 2005 Oct 01; 15(10):590-3. PubMed ID: 19810292
    [Abstract] [Full Text] [Related]

  • 11. [Level of endothelin increases in chronic congestive heart failure].
    Halawa B.
    Kardiol Pol; 1993 Mar 01; 38(3):169-72; discussion 173. PubMed ID: 8230990
    [Abstract] [Full Text] [Related]

  • 12. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome.
    Wong F, Moore K, Dingemanse J, Jalan R.
    Hepatology; 2008 Jan 01; 47(1):160-8. PubMed ID: 17886336
    [Abstract] [Full Text] [Related]

  • 13. [Morpho-functional study of the kidney in patients with kidney disease and liver disease with magnetic resonance].
    Shariat Razavi I, Stacul F, Cova M, Artero M, Carraro M, Malalan F, Pozzi Mucelli R, Dalla Palma L.
    Radiol Med; 1998 Jan 01; 95(1-2):72-81. PubMed ID: 9636731
    [Abstract] [Full Text] [Related]

  • 14. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W, Pittrow D.
    Eur J Clin Invest; 2006 Sep 01; 36 Suppl 3():78-88. PubMed ID: 16919017
    [Abstract] [Full Text] [Related]

  • 15. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D, Trägner P, Wawer A, Porst H, Daniel WG, Gross P.
    Nephrol Dial Transplant; 2005 May 01; 20(5):920-6. PubMed ID: 15788437
    [Abstract] [Full Text] [Related]

  • 16. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
    Meltzer J, Brentjens TE.
    Curr Opin Anaesthesiol; 2010 Apr 01; 23(2):139-44. PubMed ID: 20124895
    [Abstract] [Full Text] [Related]

  • 17. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function.
    Gerbes AL, Møller S, Gülberg V, Henriksen JH.
    Hepatology; 1995 Mar 01; 21(3):735-9. PubMed ID: 7875671
    [Abstract] [Full Text] [Related]

  • 18. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH, Lam HC, Cheng JT, Lin JK, Hsu JH, Lai KH, Chiang HT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct 01; 61(10):596-602. PubMed ID: 9830237
    [Abstract] [Full Text] [Related]

  • 19. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF.
    N Engl J Med; 1990 Apr 19; 322(16):1106-12. PubMed ID: 2320080
    [Abstract] [Full Text] [Related]

  • 20. Impact of pretransplant renal function on survival after liver transplantation.
    Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS.
    Transplantation; 1995 Feb 15; 59(3):361-5. PubMed ID: 7871566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.